Champions Oncology CSBR
NASDAQ CSBR
$4.79 +0.03 (+0.63%)
At close: Nov 6, 2026 · 4:00 PM EST

Champions Oncology (CSBR) Gains (Losses) on Sale of Assets & Investments (2025 - 2026)

Updated

Champions Oncology (CSBR) reported Non Operating Investment Income of -$1,000 for fiscal Q4 2026 (quarter ended Apr 30, 2026), compared with -$293,000 a year earlier.

Analysis

Champions Oncology (CSBR) Gains (Losses) on Sale of Assets & Investments (2025 - 2026) Analysis & Trends

For FY2026 (ended Apr 30, 2026), Champions Oncology posted Non Operating Investment Income of -$111,000.

  • By fiscal year, Non Operating Investment Income came in at -$293,000 in FY2025 and -$435,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Iqvia Holdings 44.71 Bn 35.96 Bn 1.50 Bn -
2 Medpace Holdings 18.26 Bn 15.91 Bn 223.89 Mn -
3 Charles River Laboratories International 16.16 Bn 15.36 Bn 357.87 Mn -
4 Icon 16.06 Bn 12.83 Bn 491.83 Mn -
5 Fortrea Holdings 2.10 Bn 1.39 Bn 139.50 Mn -
6 Ginkgo Bioworks Holdings 699.49 Mn -62.59 Mn 18.44 Mn 1.99 Mn
7 Evotec SE 601.99 Mn -1.16 Bn - -
8 Champions Oncology 66.71 Mn 41.80 Mn 7.70 Mn -
9 MindWalk Holdings 48.93 Mn 12.59 Mn 1.61 Mn -
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -1,000.00
Jan 31, 2026 -89,000.00
Jul 31, 2025 -20,000.00
Apr 30, 2025 -293,000.00
API Access

Champions Oncology Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CSBR&period=max&api_key=YOUR_API_KEY